Antifibrinolytic
Antifibrinolytic
Antifibrinolytic (pronunciation: an-ti-fib-rin-o-lyt-ic) is a type of medication that is used to prevent or slow down the breakdown of fibrin in the blood. Fibrin is a protein that helps in the formation of blood clots.
Etymology
The term "antifibrinolytic" is derived from the Greek words "anti" meaning against, "fibrin" referring to the protein involved in blood clotting, and "lytic" meaning to break down. Thus, antifibrinolytic essentially means against the breakdown of fibrin.
Usage
Antifibrinolytic drugs are often used in surgeries to reduce bleeding and in conditions like hemophilia and menorrhagia where excessive bleeding is a concern. They work by inhibiting the action of enzymes that break down fibrin, thereby promoting clot stability.
Types of Antifibrinolytics
There are several types of antifibrinolytic drugs, including Aminocaproic Acid, Tranexamic Acid, and Aprotinin. Each of these drugs works in a slightly different way to prevent the breakdown of fibrin and reduce bleeding.
Side Effects
Like all medications, antifibrinolytics can have side effects. These can include nausea, diarrhea, and an increased risk of blood clots. It is important to discuss these potential side effects with a healthcare provider before starting treatment.
Related Terms
- Fibrinolysis: The process of breaking down fibrin in the blood.
- Coagulation: The process of blood clot formation.
- Hemostasis: The process of stopping bleeding.
External links
- Medical encyclopedia article on Antifibrinolytic
- Wikipedia's article - Antifibrinolytic
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski